Can better family talks curb cannabis use in psychosis? new study aims to find out

NCT ID NCT06961877

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is developing and testing a program called Cannabis Conversation Skills for Families (CCSF) that teaches family members communication skills to encourage their young adult loved one with first episode psychosis to reduce cannabis use. The program includes education about cannabis risks and role-playing conversations. Researchers will first test the program with 10 family members, then run a pilot trial with 40 families to see if it is feasible and acceptable. The goal is to improve family communication, reduce caregiver burden, and ultimately help the young adult cut back on cannabis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cannabis Conversation Skills for Families (CCSF) - a behavioral communication skills training program
What this could lead to
If successful, this program could give families practical tools to talk about cannabis use with their loved one, potentially reducing use and easing caregiver burden.
What could go wrong
This is a very early pilot study with only 40 participants, so results may not apply to all families. The intervention focuses on family skills, not directly on the person using cannabis, so changes in use may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Caregiver Burden schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Washington

    Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.